Literature DB >> 7009006

Hemodynamic effects of calcium ion antagonists after acute myocardial infarction.

P Théroux, D D Waters, J C Debaisieux, J Szlachcic, H F Mizgala, M G Bourassa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7009006

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN： 0147-958X            Impact factor:   0.825


× No keyword cloud information.
  8 in total

1.  Action of nifedipine in ischemic heart disease.

Authors:  D D Miller; P Théroux; D D Waters; G B Pelletier
Journal:  Can Fam Physician       Date:  1983-04       Impact factor: 3.275

Review 2.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

Review 3.  Diltiazem.

Authors:  B A Britt
Journal:  Can Anaesth Soc J       Date:  1985-01

Review 4.  Diltiazem. A review of its pharmacological properties and therapeutic efficacy.

Authors:  M Chaffman; R N Brogden
Journal:  Drugs       Date:  1985-05       Impact factor: 9.546

Review 5.  Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1988-03       Impact factor: 3.727

Review 6.  Calcium antagonists. Clinical use in the treatment of angina.

Authors:  P Théroux; Y Taeymans; D D Waters
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

Review 7.  Bevantolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris.

Authors:  W H Frishman; R J Goldberg; P Benfield
Journal:  Drugs       Date:  1988-01       Impact factor: 9.546

Review 8.  The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review.

Authors:  A L Soward; G L Vanhaleweyk; P W Serruys
Journal:  Drugs       Date:  1986-07       Impact factor: 9.546
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.